CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy

Jeongshim Lee, Jee Suk Chang, Mi Ryung Roh, Minkyu Jung, Choong-Kun Lee, Byung Ho Oh, Kee Yang Chung, Woong Sub Koom, Sang Joon Shin

Cancer Research and Treatment. 2020;52(3):730-738. Published online 2020 February 13 DOI: https://doi.org/10.4143/crt.2019.598

Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy

Jeongshim Lee, Jee Suk Chang, Mi Ryung Roh, Minkyu Jung, Choong-Kun Lee, Byung Ho Oh, Kee Yang Chung, Woong Sub Koom, Sang Joon Shin

Cancer Research and Treatment. 2020;52(3):730-738

Link1

Link2 Link3

PO-1224: Clinical outcomes of malignant melanoma treated with immune checkpoint blocker in Korean patients

J. Lee, J.S. Chang, M.R. Roh, B.H. Oh, K.Y. Chung, W.S. Koom, S.J. Shin

Radiotherapy and Oncology. 2020;152:S644-S645

Link1 Link2

A retrospective study of clinical outcomes of α-blocker or finasteride monotherapy followed by combination therapy: determination of the period of combination therapy of α-blocker and finasteride

H. Son, S. Y. Cho, S. Park, J. Y. Kang, C. S. Kim, H. G. Kim

International Journal of Clinical Practice. 2013;67(4):351-355

Link1

1022MO Clinical potential of adoptive cell therapy with tumour infiltrating lymphocytes therapy in combination with checkpoint inhibitors in non-melanoma patients

A.H. Kverneland, T.H. Borch, C. Chamberlain, C.L. Lorentzen, M. Nielsen, J.W. Kjeldsen, S.K. Moerk, M. Donia, I-M. Svane

Annals of Oncology. 2020;31:S706

Link1 Link2

Immune Checkpoint Blockade in Melanoma Patients Induces Thyroid Autoimmune Disease

Jacques Orgiazzi

Clinical Thyroidology. 2016;28(10):299-302

Link1 Link2

SP-0183: Radiotherapy and immune-therapy, biological basis and potential for future clinical trials

E. Deutsch

Radiotherapy and Oncology. 2016;119:S86

Link1 Link2

SP-036: Immunity and immune toxicity: clinical management of immune checkpoint inhibition

U. Keilholz

Radiotherapy and Oncology. 2017;122:21

Link1 Link2

Sixth-week immune-nutritional-inflammatory biomarkers: Can they predict clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitors?

polat olgun, omer diker

. 2022;

Link1 Link2

Checkpoint expression on immune cells in the patients with multiple myeloma or pre-malignant diseases: Therapeutic Implication for Combination Immu

Jooeun Bae, Paul G. Richardson, Yu-Tzu Tai, Nikhil Munshi, Kenneth C. Anderson

Clinical Lymphoma Myeloma and Leukemia. 2019;19(10):e26-e27

Link1 Link2

The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy

Agnieszka Checinska, María S. Soengas

Pigment Cell & Melanoma Research. 2011;24(6):1116-1132

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.